Indeed, it was reported that SGLT2 inhibitors improved muscle insulin sensitivity, although it enhanced endogenous glucose production, and that SGLT2 inhibitors improved insulin resistance in skeletal muscle and accelerated lipolysis in adipose tissues [58,59,60,61]. This evidence concerns the gene SLC5A2 and Insulin resistance.